Somatostatin (sst) Receptor
Somatostatin (somatotropin release inhibiting factor, SRIF) is an endogenous cyclic polypeptide with two biologically active forms. It is an abundant neuropeptide and has a wide range of physiological effects on neurotransmission, secretion and cell proliferation.
Products for Somatostatin (sst) Receptor
- Cat.No. Product Name Information/Activity
-
BCC5945
BIM 23052
sst<sub>5</sub> agonist
-
BCC5913
CH 275
174688-78-9
-
BCC7364
(1R,1'S,3'R/1R,1'R,3'S)-L-054,264
208706-12-1
-
BCC7220
L-803,087 trifluoroacetate
L-803087 is a potent and selective somatostatin sst4 receptor agonist with a Ki of 0.7 nM, which is > 280-fold higher than other somatostatin receptors. L-803087 facilitates AMPA-mediated hippocampal synaptic responses in vitro and increases kainate-induced seizures in mice.
-
BCC7221
L-817,818
217480-27-8
-
BCC7361
NNC 26-9100
199522-35-5
-
BCC5643
Octreotide acetate
Octreotide is a somatostatin analog that binds to the somatostatin receptor, mainly subtypes 2, 3, and 5, increases Gi activity, and reduces intracellular cAMP production.
-
BCC7191
Seglitide
81377-02-8
-
BCC5715
Somatostatin 1-28
74315-46-1
-
BCC6248
TT 232
147159-51-1
